Hope for youngest patients with rare kidney disease

NCT ID NCT04782258

Recruiting now Disease control Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a medicine called tolvaptan in infants and children with a rare, serious genetic kidney disease (ARPKD). The main goal is to see if the drug is safe for young patients and if it can help slow down the worsening of their kidney function over 18 months. The trial is open to children from 28 days old up to 18 years old who have been diagnosed with ARPKD.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY (ARPKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

C.S. Mott Children's Hospital
RECRUITING

Ann Arbor, Michigan, 48109-5000, United States
Children's Hospital - New Orleans
WITHDRAWN

New Orleans, Louisiana, 70118, United States
Children's Hospital of Pittsburgh of UPMC
WITHDRAWN

Pittsburgh, Pennsylvania, 15213, United States
Children's National Medical Center
RECRUITING

Washington D.C., District of Columbia, 20010, United States
Cincinnati Children's Hospital Medical Center
RECRUITING

Cincinnati, Ohio, 45229-3039, United States
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States
Emory University Hospital
WITHDRAWN

Atlanta, Georgia, 30322, United States
Great Ormond Street Hospital for Children NHS Trust
RECRUITING

London, WC1N 3JH, United Kingdom
Hospital Universitari Parc Tauli
WITHDRAWN

Sabadell, Barcelona, 08208, Spain
Hospital Universitari Vall D Hebron
RECRUITING

Barcelona, 8035, Spain
Hospital Universitario Virgen del Rocío Avenida Manuel Siurot
WITHDRAWN

Seville, 41013, Spain
Instytut "Pomnik - Centrum Zdrowia Dziecka"
WITHDRAWN

Warsaw, Masovian Voivodeship, 04-730, Poland
Johns Hopkins Pediatric Specialty Clinic
RECRUITING

Baltimore, Maryland, 21287, United States
Mayo Clinic - Rochester
RECRUITING

Rochester, Minnesota, 55905, United States
Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology
WITHDRAWN

Chicago, Illinois, 60611, United States
Primary Children's Hospital
WITHDRAWN

Salt Lake City, Utah, 84113, United States
Riley Hospital for Children
WITHDRAWN

Indianapolis, Indiana, 46202-5119, United States
UZ Leuven
RECRUITING

Leuven, Vlaams Brabant, 3000, Belgium
Universitair Ziekenhuis Gent
RECRUITING

Ghent, Oost-Vlaanderen, 9000, Belgium
Universitat de Barcelona - Hospital Sant Joan de Deu Barcelona (HSJDB)
RECRUITING

Esplugues de Llobregat, Barcelona, 8950, Spain
Universitätsklinikum Köln
RECRUITING

Cologne, North Rhine-Westphalia, 50937, Germany
Université Catholique De Louvain And Cliniques St Luc
RECRUITING

Brussels, Brussels Capital, 1200, Belgium
Uniwersytecki Dzieciecy Szpital Kliniczny im. L. Zamenhofa
WITHDRAWN

Bialystok, 15-274, Poland

Conditions

Explore the condition pages connected to this study.

AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY (ARPKD)